SavedAdd your journal

Journals / Hacettepe Journal of Biology and Chemistry / 2007 / Cilt: 35 - Sayı: 2

Malondialdehyde as an indicator of ischaemic heart disease

Afife İZBIRAK
Pages
77–81
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to these results we concluded that presence of MDA in serum at certain levels may predict the insurgence of vascular pathologies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Lipids are the most involved class of molecules among the many targets of oxidative stress.
📊
Key Findings & Data:The principal and most studied product of polyunsaturated fatty acid peroxidation is malondialdehyde (MDA).
💡
Conclusion & Impact:According to these results we concluded that presence of MDA in serum at certain levels may predict the insurgence of vascular pathologies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Lipids are the most involved class of molecules among the many targets of oxidative stress. Lipid oxidation produces a number of secondary products. The principal and most studied product of polyunsaturated fatty acid peroxidation is malondialdehyde (MDA). Beside being a highly toxic molecule, malondialdehyde is also considered as a marker of lipid peroxidation. This study was intended to determine the lipid endoperoxide levels of some Turkish patients with ischaemic heart disease findings at coroner angiography and verify whether malondialdehyde could be an indicator of ischaemic heart disease. For this purpose lipid peroxide levels of the control and test groups were measured with spectrophotometric method which is based on the reaction between malondialdehyde and thiobarbituric acid. Statistical analysis of our results revealed a significant difference between the mean serum lipid peroxide levels of the patiens and the control group being 3.74±0.44 nmol/ml vs 2.72±0.53 nmol/ml respectively, and p=0.258. According to these results we concluded that presence of MDA in serum at certain levels may predict the insurgence of vascular pathologies.

🔖

Cite This Article

İZBIRAK, A. (2022). Malondialdehyde as an indicator of ischaemic heart disease. Hacettepe Journal of Biology and Chemistry, Cilt: 35 - Sayı: 2, 77–81. https://ajindex.com/articles/529365

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ceroni, C., Boraso, A., Cargnoni, AI., and Ferrari, R., Oxidative stress in cardiovascular disease: myth or fact? Arch. Biochem. Biphys.,420, 217-221, 2003
  2. Slatter, D.A., Bolton, C.H., and Bailey, A.J., The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia, 43, 550-557,2000
  3. Sohal, R.S., Mockett, R.J., and Orr, W.C., Mechanism of aging: an appraisal of the oxidative stress hypothesis. Free Radic. Biol Med., 33, 575-586, 2002
  4. Uchida, K., Role of reactive aldehyde in cardiovascular diseases. Free Radic. Biol. Med., 28, 1685-1696, 2000
  5. Pryor, W. A., and Stanley, J. P., A suggested mechanism for the production of malondialdehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation (Letter) J. Org. Chem. 40, 3615-3617,1975
  6. Esterbauer, H., Schaur,J.S., and Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic. Biol. Med., 11, 81-128, 1991
  7. Frankel, E.N., and Neff, W.E., Formation of malondialdehyde from lipid oxidation products. Biochim. Biophys. Acta., 754, 264-270, 1983, 8. Fu, M.-X., Requena, J.R., Jenkins, T.J., Baynes, J.W., Thorpe, S.R., The advanced glycation end product, Nε- (carboxymethyl)lysine, is a productof both lipid peroxidation and glycoxidation reactions. J. Biol. Chem., 271, 9982-9986,1996
  8. Haberland, M.E., Fong, D., and Cheng, L., Malondialdehyde- altered protein occurs in atheroma of Watanabe Heritable Hyperlipidemic rabbits. Science, 241, 215-217, 1988
  9. Jain, S.K., The accumulation of malondialdehyde, a product of fatty acid peroxidation, can disturb amino phospholipid organization in the membrane bilayer of human eryhrocytes. J. Biol. Chem., 259, 3391-3394, 1984
  10. Palinski,W., Rosenfeld, M.E., Yla-Herttuala, S., Gurtner, G.C., Socher, S.S., Butler, S.W., Parthasarathy, S., Carew, T.E., and Steinberg, D., Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA, 86, 1372-1376, 1989
  11. Wirtzum, J.L., and Steinberg, D., Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest., 88, 1785-1792, 1991
  12. Berliner, J.A., Navab, M., Fogelman, A.M., Frank, J.S., Demer, L.L., Edwards, P.A., Watson, A.D., and Lusis, A.J., Atherosclerosis: basic meachanisms. Oxidation, inflammation, and genetics. Circulation, 91, 2488-2496,1995
  13. Holvoet, p., Collen, D., Oxidation of low density lipoproteins in the